Showing results (431-440 of 14,086) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|September 12, 2021
Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancerOscar Lührs, Linnea Ekdahl, Barbara Geppert, et al.Gynecologic Oncology|August 30, 2025
The price of delay: Insurance-related treatment delays in patients with gynecologic cancer receiving immunotherapyMolly Morton, Julia Chalif, Jessica Sciuva, et al.Gynecologic Oncology|May 25, 2015
Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancerRoberto Tozzi, Raffaella Giannice, Stefano Cianci, et al.Gynecologic Oncology|May 24, 2015
HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history studyMarina Frimer, Chang Sun, Thomas McAndrew, et al.Gynecologic Oncology|May 24, 2015
Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancerNonna Kolomeyevskaya, Kevin H Eng, Anm Nazmul H Khan, et al.Gynecologic Oncology|May 26, 2015
Epidemiology in ovarian carcinoma: Lessons from autopsyUwe Güth, Volker Arndt, Sylvia Stadlmann, et al.Gynecologic Oncology|May 10, 2015
The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatmentDana Chase, Alison Goulder, Frederic Zenhausern, et al.Gynecologic Oncology|December 1, 1989
The inherent cellular radiosensitivity of epithelial ovarian carcinomaJ Rotmensch, J L Schwartz, R W Atcher, et al.Gynecologic Oncology|December 1, 1989
Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancerF J Montz, J B Schlaerth, J S BerekGynecologic Oncology|December 1, 1989
Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study)W T Creasman, S Gall, B N Bundy, et al.Pageof 1,409